Literature DB >> 10566187

Acute cholecystitis and pancreatitis in a patient with biliary sludge associated with the use of ceftriaxone: a rare but potentially severe complication.

G Famularo1, S Polchi, C De Simone.   

Abstract

Ceftriaxone may precipitate in the bile leading to the formation of biliary sludge. Biliary complications, even serious ones, have rarely been described in patients treated with this antibiotic. A 71-year-old woman presented to the emergency room with biliary sludge complicated by acute cholecystitis and pancreatitis after 10 days of treatment with ceftriaxone (2 g, 40 mg/kg per day). There had been no evidence of sludge or gallstones on a transabdominal ultrasonography performed 6 months earlier. The patient underwent open cholecystectomy and recovered fully. Ceftriaxone should be kept in mind as a potential cause of biliary sludge. In most cases, resolution of sludge occurs after interruption of ceftriaxone. Young subjects, patients receiving a prolonged course and a daily dose > or = 40 mg/kg, and subjects with impaired gallbladder emptying have a greater risk of ceftriaxone-associated sludge. Cholecystectomy is the definitive therapy for severe complications.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10566187

Source DB:  PubMed          Journal:  Ann Ital Med Int        ISSN: 0393-9340


  10 in total

1.  Ceftriaxone-Induced Pancreatitis.

Authors:  Muneerah M Albugami; Mohamed Ahmed; Abdulelah Bin Shihah
Journal:  Can J Hosp Pharm       Date:  2021-07-01

2.  Incidence of pancreatitis in HIV-1-infected individuals enrolled in 20 adult AIDS clinical trials group studies: lessons learned.

Authors:  Ronald B Reisler; Robert L Murphy; Robert R Redfield; Robert A Parker
Journal:  J Acquir Immune Defic Syndr       Date:  2005-06-01       Impact factor: 3.731

Review 3.  Ceftriaxone-Associated Biliary and Cardiopulmonary Adverse Events in Neonates: A Systematic Review of the Literature.

Authors:  Patrick C Donnelly; Rebecca M Sutich; Ryan Easton; Oluwatunmise A Adejumo; Todd A Lee; Latania K Logan
Journal:  Paediatr Drugs       Date:  2017-02       Impact factor: 3.022

4.  Ceftriaxone-Induced Gallstones: Case Report and Literature Review.

Authors:  Aditi Nayak; Adam Slivka
Journal:  ACG Case Rep J       Date:  2014-04-04

5.  Probable fatal drug interaction between intravenous fenretinide, ceftriaxone, and acetaminophen: a case report from a New Approaches to Neuroblastoma (NANT) Phase I study.

Authors:  Min H Kang; Judith G Villablanca; Julia L Glade Bender; Katherine K Matthay; Susan Groshen; Richard Sposto; Scarlett Czarnecki; Matthew M Ames; C Patrick Reynolds; Araz Marachelian; Barry J Maurer
Journal:  BMC Res Notes       Date:  2014-04-23

6.  Usefulness of Endoscopic Managements in Patients with Ceftriaxone-Induced Pseudolithiasis Causing Biliary Obstruction.

Authors:  Yasuhiro Doi; Yasushi Takii; Hiroyuki Ito; Norihiko Jingu; Kentaro To; Sinichiro Kimura; Koichi Kimura; Kensaku Sanefuji; Hirofumi Ikeda; Sayaka Tachibana; Takeshi Otsuka
Journal:  Case Rep Med       Date:  2017-11-02

7.  Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations.

Authors:  Dianna Wolfe; Salmaan Kanji; Fatemeh Yazdi; Pauline Barbeau; Danielle Rice; Andrew Beck; Claire Butler; Leila Esmaeilisaraji; Becky Skidmore; David Moher; Brian Hutton
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240

8.  Ceftriaxone-associated Pseudolithiasis in Elderly People: Frequency and Risk Factors.

Authors:  Kiyoshi Hotta; Naohide Hashimura; Masaki Takatsuka; Tomoki Matsuyama; Kouichirou Nakagawa; Tsuneo Yabusako; Shuhei Hosomi; Yasuhiro Fujiwara
Journal:  Intern Med       Date:  2021-12-15       Impact factor: 1.271

9.  Rapid Onset of Ceftriaxone-Induced Cholelithiasis in an Adult Patient.

Authors:  Hani Abdelaziz; Nancy Cormier; Tania Levesque; Jean St-Yves; Muhanad Al Habash; Oscar Diaz; Marie-Pierre Haberer; Dariu Calugaroiu; Mohamed Nashed
Journal:  J Glob Infect Dis       Date:  2022-02-16

10.  Ceftriaxone-associated pancreatitis captured on serial computed tomography scans.

Authors:  Nozomu Nakagawa; Nobuaki Ochi; Hiromichi Yamane; Yoshihiro Honda; Yasunari Nagasaki; Noriyo Urata; Hidekazu Nakanishi; Hirofumi Kawamoto; Nagio Takigawa
Journal:  Radiol Case Rep       Date:  2017-12-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.